CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
KMDA Kamada
- 6.660
- +0.090+1.37%
Close May 2 16:00 ET
- 6.660
- 0.0000.00%
Post 16:05 ET
382.98MMarket Cap26.64P/E (TTM)
6.738High6.590Low42.50KVolume6.620Open6.570Pre Close283.29KTurnover0.46%Turnover Ratio26.64P/E (Static)57.51MShares8.90052wk High1.48P/B61.17MFloat Cap4.60852wk Low--Dividend TTM9.18MShs Float17.450Historical High--Div YieldTTM2.25%Amplitude2.936Historical Low6.665Avg Price1Lot Size
About Kamada Company
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.
Company Profile
SymbolKMDA
Company NameKamada
Listing DateMay 31, 2013
Founded1990
CEOMr. Amir London
MarketNASDAQ
Employees374
Fiscal Year Ends12-31
AddressScience Park,2 Holzman Street
CityRehovot
ProvinceHaMerkaz
CountryIsrael
Zip Code7670402
Phone972-8-940-6472
Websitehttp://www.kamada.com
Company Executives
- Name
- Position
- Salary
- Amir London
- Chief Executive Officer
- 795.00K
- Eran Nir
- Chief Operating Officer
- 448.00K
- Chaime Orlev, C.P.A.
- Chief Financial Officer
- 589.00K
- Yael Brenner
- Vice President, Quality
- --
- Shavit Beladev
- Vice President, Plasma Operations
- --
- Orit Pinchuk
- Vice President, Regulatory Affairs and PVG
- --
- Liron Reshef
- Vice President, Human Resources
- --
- Hanni Neheman
- Vice President, Marketing & Sales
- --
- Nir Livneh
- Vice President, General Counsel and Corporate Secretary
- --
- Jon Knight
- Vice President, US Commercial Operations
- 326.00K
- Boris Gorelik
- Vice President, Business Development and Strategic Programs
- 417.00K
- Lilach Asher Topilsky
- Chairman of the Board
- --
- Professor Benjamin Dekel
- Independent Director
- --
- Lilach Payorski
- Independent Director
- --
- Karnit Goldwasser
- Independent Director
- --
- Uri Botzer
- Independent Director
- --
- Leon Y. Recanati
- Independent Director
- --
- Ishay Davidi
- Independent Director
- --
- David Tsur
- Independent Director
- --
- Assaf Itshayek
- Independent Director
- --
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025